,,iii  #aai? ,,congress  #a/ ,session   
,s4 ,,res4 #bhe  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,june #ag1 #bjbe,mr4  
,graham 7= himself1 ,mr4 ,kelly1 ,mr4   
,scott ( ,s\? ,c>ol9a1 ,mr4 ,coons1 ,mr4
 ,w>nock1 ,mr4 ,gallego1 ,mr4 ,m>key1   
,ms4 ,w>r51 ,mr4 ,b>rasso1 & ,mr4 ,van  
,holl57 submitt$ ! foll[+ resolution2   
:i* 0 consid]$ & agre$ to  ,,resolution 
,designat+ ,july #af1 #bjbe1 z          
,gliobla/oma ,aw>5ess ,day4  ,:]eas x is
 e/imat$ t m ?an #ac1jjj individuals 9 !
 ,unit$ ,/ates w be diagnos$ )          
gliobla/oma 9 #bjbe2 ,:]eas gliobla/oma 
is-- 7#a7 ! mo/ common malignant        
7canc]\s7 bra9 tumor1 acc\nt+ =         
approximately #ab ( all prim>y malignant
 bra9 tumors2 &  7#b7 ! mo/ aggressive1 
complex1 difficult to treat1 & deadly   
type ( bra9 tumor2 ,:]eas x is e/imat$ t
 m ?an #aj1jjj individuals 9 ! ,unit$   
,/ates w succumb to gliobla/oma ea* ye>2
 ,:]eas ! #e-ye> survival rate =        
gliobla/oma pati5ts is only #f4i p]c5t1 
& ! m$ian l5g? ( survival = gliobla/oma 

pati5ts is only #h mon?s2 ,:]eas        
gliobla/oma is describ$ z a disease t   
affects ! ess5ce ( self1 z ! treatm5t & 
removal ( gliobla/oma pres5ts           
significant *all5ges due to ! uniquely  
complex & fragile nature ( ! bra91 !    
prim>y organ 9 ! human body t controls n
 only cognitive ability1 b also !       
actions ( e organ & limb2 ,:]eas pati5ts
 & c>egiv]s play a critical role 9      
fur!r+ rese>* = gliobla/oma2 ,:]eas1    
relative to pati5ts ) o!r types (       
canc]s1 bra9 canc] pati5ts pay ! second 
highe/ out-(-pocket co/s = m$ical       
s]vices 9 bo? ! initial & end-(-life    
phases ( c>e2 ,:]eas1 al?\gh rese>*     
advances may fuel ! developm5t ( new    
treatm5ts = gliobla/oma1 *all5g+        
ob/acles to accel]at+ progress t[>d new 
treatm5ts = gliobla/oma rema91 & !re are
 no scre5+ or e>ly detection me?ods2    
,:]eas1 9 #bjba1 significant *anges 7   
made to ! molecul> *>act]i/ics ( a      
gliobla/oma diagnosis1 necessitat+      
critical biom>k] te/+ = pati5ts suspect$

 ( hav+ a possible gliobla/oma2 ,:]eas1 
al?\gh gliobla/oma 0 fir/ describ$ 9    
m$ical & sci5tific lit]ature 9 ! #aibjs1
 & despite its deva/at+ prognosis1 only 
#e drugs & #a m$ical device h be5       
approv$ by ! ,food & ,drug ,adm9i/ration
 to specifically treat gliobla/oma s9ce 
! #aibjs1 & ! mortality rates associat$ 
) gliobla/oma h *ang$ little dur+ ! pa/ 
#cj ye>s2 ,:]eas1 s9ce ! fir/           
,gliobla/oma ,aw>5ess ,day1 ! ,national 
,canc] ,in/itute e/abli%$ ! ,gliobla/oma
 ,!rapeutics ,network 7ref]r$ to 9 ?is  
preamble z ,,gtn7 9 #bjbj z "p ( a      
national infra/ructure to enhance &     
support ! discov]y & developm5t (       
gliobla/oma !rapies available =         
multi-in/itutional ,,gtn teams to drive 
!rapeutic ag5ts ?r\gh precl9ical /udies 
& e>ly phase cl9ical trials1 :i* are    
necess>y to rapidly evaluate pot5tial   
treatm5ts to advance t[>d cures &       
improv$ quality ( life2 & ,:]eas !re is 
a ne$ = great] public aw>5ess (         
gliobla/oma1 includ+ aw>5ess ( bo?--    

7#a7 ! urg5t unmet m$ical ne$s (        
gliobla/oma pati5ts2 &  7#b7 !          
opportunities = rese>* (1 & treatm5t    
advances =1 gliobla/oma3 ,n[1 !re=e1 be 
x  ,t ! ,s5ate-- 7#a7 designates ,july  
#af1 #bjbe1 z ,gliobla/oma ,aw>5ess     
,day2  7#b7 enc\rages increas$ public   
aw>5ess ( gliobla/oma2  7#c7 honors !   
individuals :o h di$ f ! deva/at+       
disease ( gliobla/oma or are curr5tly   
liv+ ) ! disease2  7#d7 supports ef=ts  
to develop bett] treatm5ts = gliobla/oma
 t w improve ! long-t]m prognosis =1 & !
 quality ( life (1 individuals diagnos$ 
) ! disease2  7#e7 recognizes !         
importance ( molecul> biom>k] te/+ to ! 
diagnosis & treatm5t ( gliobla/oma2     
7#f7 expresses support = ! individuals  
:o are battl+ bra9 tumors1 z well z !   
families1 fri5ds1 & c>egiv]s ( ^?       
individuals2  7#g7 urges a collaborative
 approa* to bra9 tumor rese>* among     
gov]nm5tal1 private1 & nonpr(it         
organizations1 :i* is a promis+ means ( 
advanc+ ! und]/&+ & treatm5t (          

gliobla/oma2 &  7#h7 enc\rages cont9u$  
inve/m5ts 9 gliobla/oma rese>* &        
treatm5ts1 includ+ ?r\gh ! ,gliobla/oma 
,!rapeutics ,network & o!r exi/+ bra9   
tumor rese>* res\rces4